Stobadine (STB), a cardioprotective drug, was evaluated for its effect on the intensity and habituation of exploratory behaviour in open field testing and on the levels of striatal dopamine (DA), serotonin (5-HT) and their metabolites (3,4-dihydroxyphenylacetic acid, homovanillic acid, 5-hydroxyindo
Evaluation of long-term administration of the antioxidant stobadine on exploratory behaviour in rats of both genders
✍ Scribed by M. Dubovický; E. Ujházy; P. Kovačovský; I. Rychlík; J. Janšák
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 83 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0260-437X
No coin nor oath required. For personal study only.
✦ Synopsis
Stobadine (STO) is a prospective neuro-and cardioprotective drug with high antioxidative properties.
The aim of this study was to ascertain the effect of long-term administration of STO on exploratory behaviour and habituation processes in adult virgin female and male rats. Stobadine was administered by oral gavage in a single dose of 50 mg kg ؊1 day ؊1 for a total of 56 days. The animals were tested for exploratory behaviour-intensity of motor and vertical activity in an open field test in three blocks of measurements (initial screening; after 56 days of STO administration; and 28 days after the last treatment). The rate of decline of motor activity was evaluated during four consecutive days of testing (interrupted habituation). Administration of STO resulted in transient inhibition of exploratory behaviour in female rats without overtly detectable toxicity. Exploratory behaviour of males was not affected by STO treatment.
📜 SIMILAR VOLUMES